Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cyriel Ponsioen

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
European Journal of Gastroenterology & Hepatology|August 30, 2014
Length of hospital stay and associated hospital costs with infliximab versus cyclosporine in severe ulcerative colitisMark Löwenberg, Nicolette W Duijvis, Cyriel Ponsioen, et al.
Scandinavian Journal of Gastroenterology|December 30, 2021
Assessment of endoscopic response using pan-enteric capsule endoscopy in Crohn's disease; the Sensitivity to Change (STOC) studyAdriaan Volkers, Peter Bossuyt, Jitteke de Jong, et al.
Scandinavian Journal of Gastroenterology|February 1, 2015
Impact of disease location on fecal calprotectin levels in Crohn's diseaseKrisztina B Gecse, Johannan F Brandse, Sandra van Wilpe, et al.
Metabolites|January 22, 2024
The Detection of Primary Sclerosing Cholangitis Using Volatile Metabolites in Fecal Headspace and Exhaled BreathRobert van Vorstenbosch, Kim van Munster, Danielle Pachen, et al.
Inflammatory Bowel Diseases|October 6, 2023
Crohn's Disease of the Ileoanal Pouch: A High Rate of Potential OverdiagnosesMaud Reijntjes, Djuna de Jong, Elise Wessels, et al.
Journal of Clinical Gastroenterology|March 18, 2008
A double-blind, placebo-controlled, randomized study of infliximab in primary sclerosing cholangitisDaan W Hommes, Willemien Erkelens, Cyriel Ponsioen, et al.
Nature Reviews. Disease Primers|March 14, 2025
Primary sclerosing cholangitisMichael P Manns, Annika Bergquist, Tom H Karlsen, et al.
Digestive Diseases (Basel, Switzerland)|December 8, 2015
IgG4-Associated Cholangitis--A Mimic of PSCUlrich Beuers, Lowiek M Hubers, Marieke Doorenspleet, et al.
Scandinavian Journal of Gastroenterology|January 22, 2026
Cholestatic biomarkers and symptoms in primary sclerosing cholangitis: a post-hoc analysis of the DILSTENTTim Middelburg, Nahid Montazeri, Seval Akbulut, et al.
United European Gastroenterology Journal|February 3, 2025
Tofacitinib for the treatment of chronic pouchitis: A pilot studyDjuna C de Jong, Rogier Goetgebuer, Bart L M Müskens, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
European Journal of Gastroenterology & Hepatology|August 30, 2014
Length of hospital stay and associated hospital costs with infliximab versus cyclosporine in severe ulcerative colitisMark Löwenberg, Nicolette W Duijvis, Cyriel Ponsioen, et al.
Scandinavian Journal of Gastroenterology|December 30, 2021
Assessment of endoscopic response using pan-enteric capsule endoscopy in Crohn's disease; the Sensitivity to Change (STOC) studyAdriaan Volkers, Peter Bossuyt, Jitteke de Jong, et al.
Scandinavian Journal of Gastroenterology|February 1, 2015
Impact of disease location on fecal calprotectin levels in Crohn's diseaseKrisztina B Gecse, Johannan F Brandse, Sandra van Wilpe, et al.
Metabolites|January 22, 2024
The Detection of Primary Sclerosing Cholangitis Using Volatile Metabolites in Fecal Headspace and Exhaled BreathRobert van Vorstenbosch, Kim van Munster, Danielle Pachen, et al.
Inflammatory Bowel Diseases|October 6, 2023
Crohn's Disease of the Ileoanal Pouch: A High Rate of Potential OverdiagnosesMaud Reijntjes, Djuna de Jong, Elise Wessels, et al.
Journal of Clinical Gastroenterology|March 18, 2008
A double-blind, placebo-controlled, randomized study of infliximab in primary sclerosing cholangitisDaan W Hommes, Willemien Erkelens, Cyriel Ponsioen, et al.
Nature Reviews. Disease Primers|March 14, 2025
Primary sclerosing cholangitisMichael P Manns, Annika Bergquist, Tom H Karlsen, et al.
Digestive Diseases (Basel, Switzerland)|December 8, 2015
IgG4-Associated Cholangitis--A Mimic of PSCUlrich Beuers, Lowiek M Hubers, Marieke Doorenspleet, et al.
Scandinavian Journal of Gastroenterology|January 22, 2026
Cholestatic biomarkers and symptoms in primary sclerosing cholangitis: a post-hoc analysis of the DILSTENTTim Middelburg, Nahid Montazeri, Seval Akbulut, et al.
United European Gastroenterology Journal|February 3, 2025
Tofacitinib for the treatment of chronic pouchitis: A pilot studyDjuna C de Jong, Rogier Goetgebuer, Bart L M Müskens, et al.
Pageof 4